|
"ohe y"的相關文件
顯示項目 1-15 / 15 (共1頁)
1
每頁顯示[10|25|50]項目
| 國家衛生研究院 |
2023-05-26 |
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
|
Shi, J;Shiraishi, K;Choi, J;Matsuo, K;Chen, TY;Dai, J;Hung, RJ;Chen, K;Shu, XO;Kim, YT;Landi, MT;Lin, D;Zheng, W;Yin, Z;Zhou, B;Song, B;Wang, J;Seow, WJ;Song, L;Chang, IS;Hu, W;Chien, LH;Cai, Q;Hong, YC;Kim, HN;Wu, YL;Wong, MP;Richardson, BD;Funderburk, KM;Li, S;Zhang, T;Breeze, C;Wang, Z;Blechter, B;Bassig, BA;Kim, JH;Albanes, D;Wong, JYY;Shin, MH;Chung, LP;Yang, Y;An, SJ;Zheng, H;Yatabe, Y;Zhang, XC;Kim, YC;Caporaso, NE;Chang, J;Ho, JCM;Kubo, M;Daigo, Y;Song, M;Momozawa, Y;Kamatani, Y;Kobayashi, M;Okubo, K;Honda, T;Hosgood, DH;Kunitoh, H;Patel, H;Watanabe, SI;Miyagi, Y;Nakayama, H;Matsumoto, S;Horinouchi, H;Tsuboi, M;Hamamoto, R;Goto, K;Ohe, Y;Takahashi, A;Goto, A;Minamiya, Y;Hara, M;Nishida, Y;Takeuchi, K;Wakai, K;Matsuda, K;Murakami, Y;Shimizu, K;Suzuki, H;Saito, M;Ohtaki, Y;Tanaka, K;Wu, T;Wei, F;Dai, H;Machiela, MJ;Su, J;Kim, YH;Oh, IJ;Lee, VHF;Chang, GC;Tsai, YH;Chen, KY;Huang, MS;Su, WC;Chen, YM;Seow, A;Park, JY;Kweon, SS;et al. |
| 國立成功大學 |
2023 |
Genome-wide association study of lung adenocarcinoma in East Asia and comparison with a European population
|
Shi, J.;Shiraishi, K.;Choi, J.;Matsuo, K.;Chen, T.-Y.;Dai, J.;Hung, R.J.;Chen, K.;Shu, X.-O.;Kim, Y.T.;Landi, M.T.;Lin, D.;Zheng, W.;Yin, Z.;Zhou, B.;Song, B.;Wang, J.;Seow, W.J.;Song, L.;Chang, I.-S.;Hu, W.;Chien, L.-H.;Cai, Q.;Hong, Y.-C.;Kim, H.N.;Wu, Y.-L.;Wong, M.P.;Richardson, B.D.;Funderburk, K.M.;Li, S.;Zhang, T.;Breeze, C.;Wang, Z.;Blechter, Blechter B.;Bassig, Bassig B.A.;Kim, J.H.;Albanes, D.;Wong, J.Y.Y.;Shin, M.-H.;Chung, L.P.;Yang, Yang Y.;An, S.-J.;Zheng, H.;Yatabe, Yatabe Y.;Zhang, X.-C.;Kim, Y.-C.;Caporaso, N.E.;Chang, J.;Ho, J.C.M.;Kubo, M.;Daigo, Y.;Song, M.;Momozawa, Y.;Kamatani, Y.;Kobayashi, M.;Okubo, K.;Honda, T.;Hosgood, D.H.;Kunitoh, H.;Patel, H.;Watanabe, S.-I.;Miyagi, Y.;Nakayama, H.;Matsumoto, S.;Horinouchi, Horinouchi H.;Tsuboi, M.;Hamamoto, R.;Goto, K.;Ohe, Y.;Takahashi, A.;Goto, A.;Minamiya, Y.;Hara, M.;Nishida, Y.;Takeuchi, K.;Wakai, K.;Matsuda, K.;Murakami, Y.;Shimizu, K.;Suzuki, H.;Saito, M.;Ohtaki, Y.;Tanaka, K.;Wu, T.;Wei, F.;Dai, H.;Machiela, Machiela M.J.;Su, J.;Kim, Y.H.;Oh, I.-J.;Lee, V.H.F.;Chang, G.-C.;Tsai, Y.-H.;Chen, K.-Y.;Huang, M.-S.;Su, W.-C.;Chen, Y.-M.;Seow, A.;Park, J.Y.;Kweon, S.-S.;Chen, K.-C.;Gao, Y.-T.;Qian, B.;Wu, C.;Lu, D.;Liu, J.;Schwartz, A.G.;Houlston, R.;Spitz, M.R.;Gorlov, I.P.;Wu, X.;Yang, P.;Lam, S.;Tardon, A.;Chen, Chen C.;Bojesen, S.E.;Johansson, M.;Risch, A.;Bickeb�ller, H.;Ji, B.-T.;Wichmann, H.-E.;Christiani, D.C.;Rennert, G.;Arnold, S.;Brennan, P.;McKay, J.;Field, J.K.;Shete, Shete S.S.;Le, Marchand L.;Liu, G.;Andrew, Andrew A.;Kiemeney, L.A.;Zienolddiny-Narui, S.;Grankvist, K.;Johansson, M.;Cox, A.;Taylor, F.;Yuan, J.-M.;Lazarus, P.;Schabath, M.B.;Aldrich, M.C.;Jeon, H.-S.;Jiang, S.S.;Sung, J.S.;Chen, Chen C.-H.;Hsiao, C.-F.;Jung, Y.J.;Guo, H.;Hu, Z.;Burdett, L.;Yeager, M.;Hutchinson, A.;Hicks, B.;Liu, J.;Zhu, B.;Berndt, S.I.;Wu, Wu W.;Wang, J.;Li, Y.;Choi, J.E.;Park, K.H.;Sung, Sung S.W.;Liu, Liu L.;Kang, C.H.;Wang, Wang W.-C.;Xu, J.;Guan, P.;Tan, W.;Yu, C.-J.;Yang, G.;Sihoe, A.D.L.;Chen, Y.;Choi, Y.Y.;Kim, J.S.;Yoon, H.-I.;Park, I.K.;Xu, P.;He, Q.;Wang, C.-L.;Hung, Hung H.-H.;Vermeulen, R.C.H.;Cheng, I.;Wu, J.;Lim, W.-Y.;Tsai, F.-Y.;Chan, J.K.C.;Li, J.;Chen, H.;Lin, H.-C.;Jin, L.;Liu, J.;Sawada, N.;Yamaji, T.;Wyatt, K.;Li, S.A.;Ma, H.;Zhu, M.;Wang, Z.;Cheng, S.;Li, X.;Ren, Y.;Chao, A.;Iwasaki, M.;Zhu, J.;Jiang, G.;Fei, K.;Wu, G.;Chen, Chen C.-Y.;Chen, Chen C.-J.;Yang, P.-C.;Yu, J.;Stevens, V.L.;Fraumeni, J.F.;Jr;Chatterjee, N.;Gorlova, O.Y.;Hsiung, C.A.;Amos, C.I.;Shen, H.;Chanock, S.J.;Rothman, N.;Kohno, T.;Lan, Q. |
| 臺大學術典藏 |
2022-09-15T01:09:00Z |
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials
|
Drilon A.; Siena S.; Dziadziuszko R.; Barlesi F.; Krebs M.G.; Shaw A.T.; de Braud F.; Rolfo C.; Ahn M.-J.; Wolf J.; Seto T.; Cho B.C.; Patel M.R.; Chiu C.-H.; John T.; Goto K.; Karapetis C.S.; Arkenau H.-T.; Kim S.-W.; Ohe Y.; Li Y.-C.; Chae Y.K.; Chung C.H.; Otterson G.A.; Murakami H.; Chia-Chi Lin; Tan D.S.W.; Prenen H.; Riehl T.; Chow-Maneval E.; Simmons B.; Cui N.; Johnson A.; Eng S.; Wilson T.R.; Doebele R.C. |
| 臺大學術典藏 |
2021-04-23T05:56:30Z |
TATTON: a multi-arm, phase Ib trial of osimertinib combined with selumetinib, savolitinib, or durvalumab in EGFR-mutant lung cancer
|
Oxnard G.R.;Chih-Hsin Yang;Yu H.;Kim S.-W.;Saka H.;Horn L.;Goto K.;Ohe Y.;Mann H.;Thress K.S.;Frigault M.M.;Vishwanathan K.;Ghiorghiu D.;Ramalingam S.S.;Ahn M.-J.; Oxnard G.R.; CHIH-HSIN YANG; Yu H.; Kim S.-W.; Saka H.; Horn L.; Goto K.; Ohe Y.; Mann H.; Thress K.S.; Frigault M.M.; Vishwanathan K.; Ghiorghiu D.; Ramalingam S.S.; Ahn M.-J. |
| 臺大學術典藏 |
2020-05-26T09:27:19Z |
Gefitinib or carboplatin-paclitaxel in pulmonary adenocarcinoma
|
Mok T.S; Wu Y.-L; Thongprasert S; Yang C.-H; Chu D.-T; Saijo N; Sunpaweravong P; Han B; Margono B; Ichinose Y; Nishiwaki Y; Ohe Y; CHIH-HSIN YANG; Chewaskulyong B; Jiang H; Duffield E.L; Watkins C.L; Armour A.A; Fukuoka M. |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer
|
Ranson M.;Ghiorghiu S;Dickinson P.A;Brown K.H;Cantarini M;Frewer P;Kim J.-H;Felip E;Haggstrom D;Horn L;Su W.-C;Kim S.-W;Ahn M.-J;Ramalingam S.S;Ohe Y;Planchard D;Kim D.-W;Chih-Hsin Yang;J?nne P.A; Jänne P.A; Chih-Hsin CHIH-HSIN YANG; Kim D.-W; Planchard D; Ohe Y; Ramalingam S.S; Ahn M.-J; Kim S.-W; Su W.-C; Horn L; Haggstrom D; Felip E; Kim J.-H; Frewer P; Cantarini M; Brown K.H; Dickinson P.A; Ghiorghiu S; Ranson M. |
| 臺大學術典藏 |
2020-05-26T09:26:54Z |
AZD9291 in EGFR inhibitor-resistant non-small-cell lung cancer
|
Ranson M.;Ghiorghiu S;Dickinson P.A;Brown K.H;Cantarini M;Frewer P;Kim J.-H;Felip E;Haggstrom D;Horn L;Su W.-C;Kim S.-W;Ahn M.-J;Ramalingam S.S;Ohe Y;Planchard D;Kim D.-W;Chih-Hsin Yang;J?nne P.A; Jänne P.A; Chih-Hsin CHIH-HSIN YANG; Kim D.-W; Planchard D; Ohe Y; Ramalingam S.S; Ahn M.-J; Kim S.-W; Su W.-C; Horn L; Haggstrom D; Felip E; Kim J.-H; Frewer P; Cantarini M; Brown K.H; Dickinson P.A; Ghiorghiu S; Ranson M. |
| 臺大學術典藏 |
2020-05-26T09:26:46Z |
LBA1_PR: Osimertinib as first-line treatment for EGFR mutation-positive advanced NSCLC: updated efficacy and safety results from two Phase I expansion cohorts
|
J?nne P.A.;Ohe Y;Nogami N;John T;Kim D.-W;Kurata T;Lee C.K;Chih-Hsin Yang;Ramalingam S; Ramalingam S; CHIH-HSIN YANG; Lee C.K; Kurata T; Kim D.-W; John T; Nogami N; Ohe Y; Jänne P.A. |
| 臺大學術典藏 |
2020-05-26T09:26:46Z |
LBA1_PR: Osimertinib as first-line treatment for EGFR mutation-positive advanced NSCLC: updated efficacy and safety results from two Phase I expansion cohorts
|
J?nne P.A.;Ohe Y;Nogami N;John T;Kim D.-W;Kurata T;Lee C.K;Chih-Hsin Yang;Ramalingam S; Ramalingam S; CHIH-HSIN YANG; Lee C.K; Kurata T; Kim D.-W; John T; Nogami N; Ohe Y; Jänne P.A. |
| 臺大學術典藏 |
2020-05-26T09:26:40Z |
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
|
Fukuoka M.;Rukazenkov Y;Haddad V;Young H;Mok T.S.K;Yang J.-J;Ichinose Y;Ohe Y;Sunpaweravong P;Chewaskulyong B;Margono B;Han B;Chih-Hsin Yang;Thongprasert S;Saijo N;Wu Y.-L; Wu Y.-L; Saijo N; Thongprasert S; CHIH-HSIN YANG; Han B; Margono B; Chewaskulyong B; Sunpaweravong P; Ohe Y; Ichinose Y; Yang J.-J; Mok T.S.K; Young H; Haddad V; Rukazenkov Y; Fukuoka M. |
| 臺大學術典藏 |
2020-05-26T09:26:40Z |
Efficacy according to blind independent central review: Post-hoc analyses from the phase III, randomized, multicenter, IPASS study of first-line gefitinib versus carboplatin/paclitaxel in Asian patients with EGFR mutation-positive advanced NSCLC
|
Fukuoka M.;Rukazenkov Y;Haddad V;Young H;Mok T.S.K;Yang J.-J;Ichinose Y;Ohe Y;Sunpaweravong P;Chewaskulyong B;Margono B;Han B;Chih-Hsin Yang;Thongprasert S;Saijo N;Wu Y.-L; Wu Y.-L; Saijo N; Thongprasert S; CHIH-HSIN YANG; Han B; Margono B; Chewaskulyong B; Sunpaweravong P; Ohe Y; Ichinose Y; Yang J.-J; Mok T.S.K; Young H; Haddad V; Rukazenkov Y; Fukuoka M. |
| 臺大學術典藏 |
2020-05-26T09:26:30Z |
Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer
|
Ramalingam S.S; CHIH-HSIN YANG; Lee C.K; Kurata T; Kim D.-W; John T; Nogami N; Ohe Y; Mann H; Rukazenkov Y; Ghiorghiu S; Stetson D; Markovets A; Barrett J.C; Thress K.S; Jänne P.A.; J?nne P.A.;Thress K.S;Barrett J.C;Markovets A;Stetson D;Ghiorghiu S;Rukazenkov Y;Mann H;Ohe Y;Nogami N;John T;Kim D.-W;Kurata T;Lee C.K;Chih-Hsin Yang;Ramalingam S.S |
| 臺大學術典藏 |
2020-05-26T09:26:30Z |
Osimertinib as first-line treatment of EGFR mutation-positive advanced non-small-cell lung cancer
|
Ramalingam S.S; CHIH-HSIN YANG; Lee C.K; Kurata T; Kim D.-W; John T; Nogami N; Ohe Y; Mann H; Rukazenkov Y; Ghiorghiu S; Stetson D; Markovets A; Barrett J.C; Thress K.S; Jänne P.A.; J?nne P.A.;Thress K.S;Barrett J.C;Markovets A;Stetson D;Ghiorghiu S;Rukazenkov Y;Mann H;Ohe Y;Nogami N;John T;Kim D.-W;Kurata T;Lee C.K;Chih-Hsin Yang;Ramalingam S.S |
| 臺大學術典藏 |
2020-05-25T07:35:02Z |
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1�V2 trials
|
Rolfo C; de Braud F; Drilon A; Siena S; Dziadziuszko R; Barlesi F; Krebs M.G; Shaw A.T; Doebele R.C.;Wilson T.R;Eng S;Johnson A;Cui N;Simmons B;Chow-Maneval E;Riehl T;Prenen H;Tan D.S.W;Chia-Chi Lin;Murakami H;Otterson G.A;Chung C.H;Chae Y.K;Li Y.-C;Ohe Y;Kim S.-W;Arkenau H.-T;Karapetis C.S;Goto K;John T;Chiu C.-H;Patel M.R;Cho B.C;Seto T;Wolf J;Ahn M.-J;Rolfo C;de Braud F;Shaw A.T;Krebs M.G;Barlesi F;Dziadziuszko R;Siena S;Drilon A; Ahn M.-J; Wolf J; Seto T; Cho B.C; Patel M.R; Chiu C.-H; John T; Goto K; Karapetis C.S; Arkenau H.-T; Kim S.-W; Ohe Y; Li Y.-C; Chae Y.K; Chung C.H; Otterson G.A; Murakami H; Chia-Chi Lin; Tan D.S.W; Prenen H; Riehl T; Chow-Maneval E; Simmons B; Cui N; Johnson A; Eng S; Wilson T.R; Doebele R.C. |
| 臺大學術典藏 |
2020-05-25T07:35:02Z |
Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1�V2 trials
|
Rolfo C; de Braud F; Drilon A; Siena S; Dziadziuszko R; Barlesi F; Krebs M.G; Shaw A.T; Doebele R.C.;Wilson T.R;Eng S;Johnson A;Cui N;Simmons B;Chow-Maneval E;Riehl T;Prenen H;Tan D.S.W;Chia-Chi Lin;Murakami H;Otterson G.A;Chung C.H;Chae Y.K;Li Y.-C;Ohe Y;Kim S.-W;Arkenau H.-T;Karapetis C.S;Goto K;John T;Chiu C.-H;Patel M.R;Cho B.C;Seto T;Wolf J;Ahn M.-J;Rolfo C;de Braud F;Shaw A.T;Krebs M.G;Barlesi F;Dziadziuszko R;Siena S;Drilon A; Ahn M.-J; Wolf J; Seto T; Cho B.C; Patel M.R; Chiu C.-H; John T; Goto K; Karapetis C.S; Arkenau H.-T; Kim S.-W; Ohe Y; Li Y.-C; Chae Y.K; Chung C.H; Otterson G.A; Murakami H; Chia-Chi Lin; Tan D.S.W; Prenen H; Riehl T; Chow-Maneval E; Simmons B; Cui N; Johnson A; Eng S; Wilson T.R; Doebele R.C. |
顯示項目 1-15 / 15 (共1頁)
1
每頁顯示[10|25|50]項目
|
